Clinical trial
Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in…
NCT00314054 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00314054 |
|---|---|
| Title | Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults |
| Official title | An Open-Label, Single-Dose, Parallel-Group Study of the Pharmacokinetics and Safety of HCV-796 in Subjects With Chronic Hepatic Impairment and in Matched Healthy Adults |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Collaborators | ViroPharma Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Hepatitis C, Hepatic Insufficiency |
| Intervention type | Drug |
| Interventions | HCV-796 |
| Enrollment | 27 |
| Start date | May 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Apr 12, 2006 |
| Last update posted | Apr 14, 2008 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: